Rhythm-specific pharmacological modulation of subthalamic activity in Parkinson's disease. - Wikidata - wikimedia - TriplyDB

Rhythm-specific pharmacological modulation of subthalamic activity in Parkinson's disease.

Rhythm-specific pharmacological modulation of subthalamic activity in Parkinson's disease.

http://www.wikidata.org/entity/Q45068390

about

Oscillations and the basal ganglia: motor control and beyond Functional neuroimaging in Parkinson's disease Basal ganglia activity patterns in parkinsonism and computational modeling of their downstream effects Alterations in brain connectivity underlying beta oscillations in Parkinsonism Encoding of sequence boundaries in the subthalamic nucleus of patients with Parkinson's disease.Movement preparation and bilateral modulation of beta activity in aging and Parkinson's disease.Resonance in subthalamo-cortical circuits in Parkinson's disease The electrocorticogram signal can be modulated with deep brain stimulation of the subthalamic nucleus in the hemiparkinsonian rat Relationship between oscillatory activity in the cortico-basal ganglia network and parkinsonism in MPTP-treated monkeys.Subthalamic local field potentials in Parkinson's disease and isolated dystonia: An evaluation of potential biomarkers.Network perspectives on the mechanisms of deep brain stimulation.Fine temporal structure of beta oscillations synchronization in subthalamic nucleus in Parkinson's disease.Nonlinear coupling in the human motor system.Functional brain networks and abnormal connectivity in the movement disorders.Hypersynchrony despite pathologically reduced beta oscillations in patients with Parkinson's disease: a pharmaco-magnetoencephalography study.Beta-coupled high-frequency activity and beta-locked neuronal spiking in the subthalamic nucleus of Parkinson's disease Deep brain stimulation in Parkinson's disease Improved efficacy of temporally non-regular deep brain stimulation in Parkinson's disease Theoretical analysis of the local field potential in deep brain stimulation applications Deep brain stimulation can suppress pathological synchronisation in parkinsonian patients.Pathophysiology of parkinsonism.Alterations in neuronal activity in basal ganglia-thalamocortical circuits in the parkinsonian state.Functional correlates of exaggerated oscillatory activity in basal ganglia output in hemiparkinsonian rats.Oscillatory Activity in Basal Ganglia and Motor Cortex in an Awake Behaving Rodent Model of Parkinson's Disease.Bilateral functional connectivity of the basal ganglia in patients with Parkinson's disease and its modulation by dopaminergic treatment.Nicotinic receptor subtype-selective circuit patterns in the subthalamic nucleus.Time and frequency-dependent modulation of local field potential synchronization by deep brain stimulation.Web-based telemonitoring and delivery of caregiver support for patients with Parkinson disease after deep brain stimulation: protocol Subthalamic nucleus activity in the awake hemiparkinsonian rat: relationships with motor and cognitive networks Sixty hertz neurostimulation amplifies subthalamic neural synchrony in Parkinson's disease.Classification of pallidal oscillations with increasing parkinsonian severity.Clustered Desynchronization from High-Frequency Deep Brain Stimulation.Intermittent neural synchronization in Parkinson's disease.Beta frequency synchronization in basal ganglia output during rest and walk in a hemiparkinsonian rat.β band stability over time correlates with Parkinsonian rigidity and bradykinesia.State-dependent spike and local field synchronization between motor cortex and substantia nigra in hemiparkinsonian rats.Practice changes beta power at rest and its modulation during movement in healthy subjects but not in patients with Parkinson's disease.Deep brain stimulation suppresses pallidal low frequency activity in patients with phasic dystonic movements Ventral Medial Thalamic Nucleus Promotes Synchronization of Increased High Beta Oscillatory Activity in the Basal Ganglia-Thalamocortical Network of the Hemiparkinsonian Rat.Implantable neurotechnologies: bidirectional neural interfaces--applications and VLSI circuit implementations.

P2860

Q26999873-9C3F89EB-4F50-4243-A991-25BC22C2EA0D Q27013767-582B581E-39A7-459B-8288-71B851EA8DA6 Q28271277-307E2E79-ED6A-4844-B422-1B5FA42A4A14 Q28476509-3E1B52CB-76D1-4AA0-8207-A2DE7EF084D8 Q30364799-D41E2450-7DB4-446A-A494-926DC53C031B Q30418885-AD5010FA-6223-43A0-AABD-15998FBDF302 Q30488968-6632A5F6-89C0-4593-9AD3-56AACE4C97F2 Q30490320-61F34B7D-4CFC-4325-BC50-36ED3EC6C0E2 Q30611028-2ADE1EF1-F53E-4A2D-B026-761BBB9FFCCC Q30726509-24F1E0CE-9ADE-40DB-BB43-876F68537B7B Q33823530-64562B2C-E8A0-4881-B0C6-07571597CA88 Q33841385-5E1F9874-BA95-45CF-86FF-A48D8A491337 Q34071284-52006266-162F-4127-863F-1F343FC99DD2 Q34114125-DD329406-67D8-4F98-B51B-C2C830F0A500 Q34146969-F0FCF4FF-7ECD-46DD-BBBF-B758B3F5F648 Q34197705-1450AC74-5B10-4F63-9426-29A50560F685 Q34255809-3AC27958-0E0C-4149-9B0A-A3FBFDA87F45 Q34302698-38FFB50A-A98A-422D-89E1-5F46A8D93FE4 Q34652357-8A31E342-6E5B-4AAC-9272-B294E8256ACF Q34768897-A4001818-2615-440C-8E2D-62EB34DD5C3A Q34777496-3B34BA81-7949-4D9E-A1A5-DA06CB37234C Q35053448-13EB4811-4998-49A6-9BFA-1F458447B0C5 Q35053960-924160A9-BD7E-45AC-BC1F-DB24F0DD6CE9 Q35056590-BB4D03C7-1ABA-4722-BFAD-845187BEAFE9 Q35077707-1BAAC6E9-18CB-4843-B84E-9CD6584120F4 Q35142884-9B4EA235-D10E-4BF9-83A2-DD33E177CC9F Q35207690-08DFC4F6-67E2-4F46-B620-3BB4E218D914 Q35223158-5B1028F5-BA47-451A-90D4-F61F0A3984F8 Q35547915-25616517-7A39-47B7-B62F-1121565BBE1F Q35586429-E2E1591C-4F54-4D58-B3BA-3E4748EA6463 Q35867463-72B0D610-AF43-4310-BF00-08CA7596E98B Q35880462-4C9BFE07-AAC8-4F71-8996-FDAD4458AB99 Q35944610-A69998DA-B9A5-4122-A03A-41905EA6D750 Q36062933-A4CC80FA-CD73-40A8-8C35-7DD5531C289B Q36103763-864746D8-264C-4FAE-9935-6EEC7689526B Q36178312-254DA176-08B9-45E3-8BE6-F76D6D0EC63F Q36186544-9593B143-386B-4838-8778-FAE954D92DC7 Q36745301-8B62092A-E740-4F2E-87C2-2C77C3A7C10F Q36792572-34714717-5D60-4CB1-84E0-5327DA0FF098 Q36823055-03A5B173-3CBE-4508-92D8-DB455F351769

P2860

Rhythm-specific pharmacological modulation of subthalamic activity in Parkinson's disease.

http://www.wikidata.org/entity/Q45068390

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh-hant

name

Rhythm-specific pharmacologica ...... tivity in Parkinson's disease.

@en

Rhythm-specific pharmacologica ...... tivity in Parkinson's disease.

@nl

type

label

Rhythm-specific pharmacologica ...... tivity in Parkinson's disease.

@en

Rhythm-specific pharmacologica ...... tivity in Parkinson's disease.

@nl

prefLabel

Rhythm-specific pharmacologica ...... tivity in Parkinson's disease.

@en

Rhythm-specific pharmacologica ...... tivity in Parkinson's disease.

@nl

P1433

Q45068390-AE4A4632-EEF5-4B94-8D37-A557A4CD3B9B

P1476

Q45068390-BF609C27-AAFC-4099-9AE7-F909F424F79E

P2093

Q45068390-1B3579FD-DD50-4CA3-8EFA-1DD0DFA79518

Q45068390-1CB216D0-55AE-484E-BBC4-A2F11C8766A6

Q45068390-360073B1-6AAA-4362-8A97-7FD4039260BE

Q45068390-47DD6D24-05D1-46AF-922E-A18EA7ABD8F7

Q45068390-4880C832-F7F8-4058-BEA6-2AAEF5620085

Q45068390-A0FEC08D-D738-45FC-A791-E4BF3298E673

Q45068390-B37B328B-E2D4-4F07-B7B6-8798A18FDA0E

Q45068390-BEEADFC0-785B-45FF-8146-7E0259E90924

Q45068390-E7FC5B9D-A1AA-4624-AF5A-09B660C9C3D8

P304

Q45068390-35A74B97-E293-4532-A0BA-BF5A19DF54F1

P31

Q45068390-865A44CF-3F62-41C6-8C81-5E2E984C4217

P356

Q45068390-DC926B4D-E97A-4B91-9083-C113D87A978A

P407

Q45068390-C929F648-B973-4AAB-9526-86567D684F85

P433

Q45068390-CB23AB75-DF16-4AFB-B3AC-6D93D8C4F3EF

P478

Q45068390-BF3E76CD-D8ED-44FD-A8CD-BAA376D6C15B

P577

Q45068390-36751E27-81FB-4128-A7F1-986238B2DF98

P698

Q45068390-586AE083-7ACB-440D-85EB-A8371D531703

P921

Q45068390-1076FED3-A213-4048-8A31-50F1770D41B5

Q45068390-FC00D1DA-EAF7-462E-B458-BA1779D3EE42

P356

J.EXPNEUROL.2004.06.001

P1433

Experimental Neurology

P1476

Rhythm-specific pharmacologica ...... tivity in Parkinson's disease.

@en

P2093

Bianchi AM

http://www.w3.org/2001/XMLSchema#string

Foffani G

http://www.w3.org/2001/XMLSchema#string

Locatelli M

http://www.w3.org/2001/XMLSchema#string

Moxon KA

http://www.w3.org/2001/XMLSchema#string

Pellegrini M

http://www.w3.org/2001/XMLSchema#string

Pesenti A

http://www.w3.org/2001/XMLSchema#string

Priori A

http://www.w3.org/2001/XMLSchema#string

Tamma F

http://www.w3.org/2001/XMLSchema#string

Villani RM

http://www.w3.org/2001/XMLSchema#string

P304

369-379

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.EXPNEUROL.2004.06.001

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

189

http://www.w3.org/2001/XMLSchema#string

P577

2004-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15380487

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease